The RELENT Consortium is a multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis. The whole group consists of 13 partners from 6 different European countries, and one partner from Australia whose expertise is not available elsewhere in the world.